Clinical Trials in Chur, Kanton Graubünden
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled281 locationsNCT06393374
Recruiting
Phase 2
NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
Breast Cancer
Swiss Cancer Institute50 enrolled8 locationsNCT06452394